ClinicalTrials.govpublic full text
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
systemic lupus erythematosus, sle, monoclonal antibody, anifrolumab, parallel-group treatment, pediatric participants, standard of care therapy, intravenous, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 870271
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.